ask="45.60"
ask_size="500"
average_daily_volume="1219020"
bid="43.00"
bid_size="1600"
book_value="10.71"
change="N/A"
change_from_200_day_moving_average="-6.34"
change_from_50_day_moving_average="5.05"
change_from_52_week_high="-34.50"
change_From_52_week_low="14.23"
change_in_percent="N/A"
close="45.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-408.44M"
eps_estimate_current_year="-5.01"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.66"
ex_dividend_date="N/A"
float_shares="70964000"
high="N/A"
high_52_weeks="80.11"
last_trade_date="2/13/2017"
last_trade_price="45.61"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="31.38"
market_capitalization="3.92B"
moving_average_200_day="51.95"
moving_average_50_day="40.56"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="N/A"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="-12.21%"
percent_change_from_50_day_moving_average="+12.46%"
percent_change_from_52_week_high="-43.07%"
percent_change_from_52_week_low="+45.35%"
previous_close="45.61"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.26"
price_per_sales="83.08"
revenue="47.16M"
shares_outstanding="85900000"
short_ratio="10.08"
stock_exchange="NMS"
symbol="ALNY"
volume="0"
weeks_range_52="31.38 - 80.11"
